StabiLink MIS System

David Field, CEO, Southern Spine LLC, announced the launch of the company’s new medical device, the StabiLink MIS Spinal Fixation System, which has recently received its FDA clearance and CE Mark. The minimally invasive system is designed to provide spinal fixation in lumbar fusion procedures, including the treatment of degenerative disc disease, spinal tumors, and trauma.

“We believe StabiLink MIS Spinal Fixation System represents 'the best first option' for many patients and can be used to treat a number of spinal conditions with much less tissue trauma than traditional spinal fixation systems,” Field says. “Patients and surgeons are demanding procedures that fill the void between non-surgical spine treatments and the more traditional, invasive spinal fusion procedures. The StabiLink MIS Spinal Fixation System successfully addresses this “void” in treatment options for many patients and surgeons.”

The principal benefit of the StabiLink MIS Spinal Fixation System is that it is placed between the spinous processes, away from the neural elements including the spinal cord and spinal nerves. The implant is placed through a 2cm to 4cm incision in the back using the innovative, patented PG Precision Guided Inserter/Compressor. The PG Inserter/Compressor is an All-in-One instrument that redefines ease-of-use and allows the surgeon to quickly and accurately place the StabiLink implant with or without removal of the interspinous ligaments. In addition, implant insertion and compression is safely achieved without the need for multiple instruments, including “bulky” compressors, reducing overall procedure time. The anterior “tray” design of the StabiLink implant creates an ideal containment area for the maximum amount of bone graft material to optimize bony fixation between the spinous process.